Gene · 4084
MXD1: MAX dimerization protein 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MXD1: MAX dimerization protein 1. Genes, record 4084. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4084
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q05195 | Max dimerization protein 1 | 221 | 5 | Ensembl, GeneID, HGNC |
Source UniProt
Patents45
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4641201 A2 | 2025-10-29 | 1928 | Q05195 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15317 | Q05195 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1928 | Q05195 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 31911 | Q05195 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15317 | Q05195 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15317 | Q05195 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 31911 | Q05195 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 15156 | Q05195 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 31911 | Q05195 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 49524 | Q05195 | Espacenet |
1 to 10 of 45
See all 45 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,780
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MXD1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 14 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 14 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 13 | 2025 |
| P30MH092177 | Comprehensive NeuroHIV Center | 12 | 2025 |
| R01GM074215 | Kinetochore Specification and Function | 7 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 6 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 6 | 2025 |
| P20GM103423 | The Maine Biomedical Research Network (INBRE) | 5 | 2025 |
| P30CA042014 | Cancer Center Support Grant | 5 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 4 | 2025 |
1 to 10 of 1,780Source NIH's project files
See all 1,780 nih grantsPapers2,767
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Computed tomography analysis of glenoid size and bone depth: insights for baseplate fixation in reverse shoulder arthroplasty. | JSES Rev Rep Tech | 2026 | 42750994 | PubTator, text mining | PubMed |
| Spindle Assembly Checkpoint Competency Determines Sensitivity to KIF18A Inhibition in Small Cell Lung Cancer. | Cancer Res Commun | 2026 | 42647139 | PubTator, text mining | PubMed |
| Spindle Assembly Checkpoint Competency Determines Sensitivity to KIF18A Inhibition in Small-Cell Lung Cancer. | bioRxiv | 2026 | 42619900 | PubTator, text mining | PubMed |
| Yorkie/YAP Interactors: Fine-Tuning the Hippo Pathway Output. | Cold Spring Harb Perspect Biol | 2026 | 42575696 | PubTator, text mining | PubMed |
| Exploring the potential involvement of UFSP2 in spindle assembly checkpoint regulation in breast cancer. | Mol Biol Rep | 2026 | 42430000 | PubTator, text mining | PubMed |
| hSpindly dynamics modulate spindle assembly checkpoint signaling, promoting resistance to mitotic inhibitors. | iScience | 2026 | 42338480 | PubTator, text mining | PubMed |
| Norlichexanthone, a shunt product of Griseofulvin, disrupts spindle assembly checkpoint and nucleocytoplasmic transport by targeting TPR in the nuclear pore complex. | Bioorg Chem | 2026 | 42330849 | PubTator, text mining | PubMed |
| Identification and analysis of diagnostic senescence-related gene signatures for acute myocardial infarction based on multi-omics data and machine learning. | Front Immunol | 2026 | 42327787 | PubTator, text mining | PubMed |
| Folate deficiency correlates with severity of primary biliary cholangitis via modulating key regulatory genes. | Front Nutr | 2026 | 42317867 | PubTator, text mining | PubMed |
| Membrane ATG8ylation in secretory autophagy. | Autophagy | 2026 | 42178909 | PubTator, text mining | PubMed |
1 to 10 of 2,767
See all 2,767 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4084
GET https://conductscience.org/api/genes/v1/4084/patents?page=2